ロード中...
Ensemble docking to difficult targets in early-stage drug discovery: Methodology and application to fibroblast growth factor 23
Ensemble docking is now commonly used in early-stage in silico drug discovery and can be used to attack difficult problems such as finding lead compounds which can disrupt protein–protein interactions. We give an example of this methodology here, as applied to fibroblast growth factor 23 (FGF23), a...
保存先:
| 出版年: | Chem Biol Drug Des |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983124/ https://ncbi.nlm.nih.gov/pubmed/28944571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cbdd.13110 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|